SecBot SecBot
SECBOTREPLAY Home › Report › JATT

JATT · Talawar merger vote Dec 2

JATT II Acquisition Corp. · DEFM14A filed Nov 9, 2026 at 16:45 ET

At the news

NEUTRALIMPACT 5/10

DEFM14A filed Nov 9, 2026 at 16:45 ET

JATT II Acquisition Corp. is holding a shareholder vote on December 2, 2026 to approve its business combination with Talawar Tx Inc., a biopharmaceutical company. Under the deal, Talawar stockholders will receive approximately 12.5 million shares of the combined company (valued at $120 million at $10/share), JATT public shareholders will receive one share per JATT share, and a $225 million PIPE at $10/share will close concurrently. The JATT board unanimously recommends approval (with Dr. Sidhu recused due to conflicts as Talawar's majority stockholder and Khanda's CEO), and Houlihan Capital opined the consideration is fair to JATT's unaffiliated shareholders.

  • JATT shareholders vote on December 2, 2026 to approve merger with Talawar Tx Inc.
  • Talawar equity valued at $120 million, paid in ~12.5 million shares of combined company at $10/share
  • $225 million PIPE at $10/share (22.5 million shares) from institutional investors including Access affiliates
  • JATT public shareholders get 1 share per share; redemption price ~$10.19/share as of Nov 3, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access